Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence and Adhesion Assessment Between Two Rivastigmine Transdermal Patch Formulations

NCT07464340 is registered in ClinicalTrials.gov with Zodiac Produtos Farmaceuticos S.A. as lead sponsor.

NCT NCT07464340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07464340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence and Adhesion Assessment Between Two Rivastigmine Transdermal Patch Formulations
Lead sponsor
Zodiac Produtos Farmaceuticos S.A.
Phase
Phase 1
Overall status
Completed
Start date
May 12, 2023
Completion date
July 3, 2023
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence study in healthy subjects